ACT001 inhibits glioma cell proliferation by inhibiting PI3K/AKT activation 14 and AEBP1 activates PI3K/AKT signaling through upregulation of PI3KCB transcription 18. This evidence concerns the gene AEBP1 and central nervous system cancer.